SG11202012472TA - Improved proteomic multiplex assays - Google Patents

Improved proteomic multiplex assays

Info

Publication number
SG11202012472TA
SG11202012472TA SG11202012472TA SG11202012472TA SG11202012472TA SG 11202012472T A SG11202012472T A SG 11202012472TA SG 11202012472T A SG11202012472T A SG 11202012472TA SG 11202012472T A SG11202012472T A SG 11202012472TA SG 11202012472T A SG11202012472T A SG 11202012472TA
Authority
SG
Singapore
Prior art keywords
proteomic
improved
multiplex assays
multiplex
assays
Prior art date
Application number
SG11202012472TA
Inventor
Stephan Kraemer
Evaldas Katilius
Dominic Zichi
Original Assignee
Somalogic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Somalogic Inc filed Critical Somalogic Inc
Publication of SG11202012472TA publication Critical patent/SG11202012472TA/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/6848Nucleic acid amplification reactions characterised by the means for preventing contamination or increasing the specificity or sensitivity of an amplification reaction
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2570/00Omics, e.g. proteomics, glycomics or lipidomics; Methods of analysis focusing on the entire complement of classes of biological molecules or subsets thereof, i.e. focusing on proteomes, glycomes or lipidomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
SG11202012472TA 2018-06-22 2019-06-19 Improved proteomic multiplex assays SG11202012472TA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862688770P 2018-06-22 2018-06-22
PCT/US2019/038022 WO2019246289A1 (en) 2018-06-22 2019-06-19 Improved proteomic multiplex assays

Publications (1)

Publication Number Publication Date
SG11202012472TA true SG11202012472TA (en) 2021-01-28

Family

ID=68983070

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202012472TA SG11202012472TA (en) 2018-06-22 2019-06-19 Improved proteomic multiplex assays

Country Status (12)

Country Link
US (1) US20210247387A1 (en)
EP (1) EP3810563A4 (en)
JP (1) JP2021528646A (en)
KR (1) KR20210034597A (en)
CN (1) CN112638845A (en)
AU (1) AU2019290130A1 (en)
BR (1) BR112020026129B1 (en)
CA (1) CA3104041A1 (en)
IL (1) IL279254A (en)
MX (1) MX2020013814A (en)
SG (1) SG11202012472TA (en)
WO (1) WO2019246289A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220333113A1 (en) * 2019-10-16 2022-10-20 Somalogic Operating Co., Inc. Nucleic Acid Compounds that Bind to Retinoic Acid-Inducible Gene I Protein

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2186879B1 (en) * 2002-10-03 2016-11-23 Norman Leigh Anderson High sensitivity quantitation of peptides by mass spectrometry
NZ550604A (en) * 2004-04-20 2010-09-30 Dendritic Nanotechnologies Inc Dendritic polymers with enhanced amplification and interior functionality
US20070166740A1 (en) * 2006-01-17 2007-07-19 Somalogic, Incorporated Multiplexed analyses of test samples
US7855054B2 (en) * 2007-01-16 2010-12-21 Somalogic, Inc. Multiplexed analyses of test samples
US20110136099A1 (en) * 2007-01-16 2011-06-09 Somalogic, Inc. Multiplexed Analyses of Test Samples
ES2647587T3 (en) * 2007-07-17 2017-12-22 Somalogic, Inc. Aptamers with uridines and / or substituted thymidines in position 5 with a benzyl group
ES2559758T3 (en) * 2008-09-09 2016-02-15 Somalogic, Inc. Biomarkers of lung cancer and their uses
GB2470939A (en) * 2009-06-10 2010-12-15 Dna Supernova Ltd Signal amplification microspheres
MX2020003168A (en) * 2010-04-12 2022-05-31 Somalogic Inc 5-position modified pyrimidines and their use.
CA2801110C (en) * 2010-07-09 2021-10-05 Somalogic, Inc. Lung cancer biomarkers and uses thereof
WO2013055829A1 (en) * 2011-10-11 2013-04-18 Nestec S.A. Proximity-based assays for the detection of signaling protein expression and activation
MY170164A (en) * 2012-06-07 2019-07-09 Somalogic Inc Aptamer-based multiplexed assays
US9103837B2 (en) * 2012-11-07 2015-08-11 Somalogic, Inc. Chronic obstructive pulmonary disease (COPD) biomarkers and uses thereof
WO2014093698A1 (en) * 2012-12-12 2014-06-19 The Methodist Hospital Research Institute Multi-aptamer-based, cell-specific, one-step tumor cell detection assays
EP3049523B1 (en) * 2013-09-24 2019-08-07 Somalogic, Inc. Multiaptamer target detection
US9587268B2 (en) * 2014-01-29 2017-03-07 Agilent Technologies Inc. Fast hybridization for next generation sequencing target enrichment
CN107923918A (en) * 2015-09-09 2018-04-17 私募蛋白质体公司 Method for developing personalized drug therapy plan and the targeted drug exploitation composed based on protein group

Also Published As

Publication number Publication date
KR20210034597A (en) 2021-03-30
IL279254A (en) 2021-01-31
CN112638845A (en) 2021-04-09
AU2019290130A1 (en) 2021-01-28
CA3104041A1 (en) 2019-12-26
BR112020026129A8 (en) 2022-10-18
MX2020013814A (en) 2021-04-13
US20210247387A1 (en) 2021-08-12
BR112020026129A2 (en) 2021-03-16
EP3810563A1 (en) 2021-04-28
WO2019246289A1 (en) 2019-12-26
EP3810563A4 (en) 2022-03-23
JP2021528646A (en) 2021-10-21
BR112020026129B1 (en) 2023-10-10

Similar Documents

Publication Publication Date Title
SG11202106214YA (en) Novel anti-ccr8 antibody
IL280780A (en) Anti-tigit antibodies
GB201803393D0 (en) Novel compounds
IL279352A (en) Il-11ra antibodies
IL280013A (en) Anti-il36r antibodies
GB201803394D0 (en) Novel compounds
IL278010A (en) Galectin-10 antibodies
EP3307867A4 (en) Image diffrentiated multiplex assays
IL277030A (en) Antibodies
SG11202106171WA (en) Anti-btla antibodies
IL281594A (en) Anti-klrg1 antibodies
GB201806084D0 (en) Antibodies
IL279254A (en) Improved proteomic multiplex assays
GB201820413D0 (en) Multiplexed Assay
SG11202006798QA (en) Zinc-binder based ebna1-specific compounds
IL287629A (en) Assays
GB201819952D0 (en) Antibodies
GB201817312D0 (en) Antibodies
GB201817311D0 (en) Antibodies
GB201817309D0 (en) Antibodies
GB201817313D0 (en) Antibodies
GB201806099D0 (en) Galectin-10 Antibodies
EP3807646C0 (en) Sample preparation for proteomic assays
GB201803414D0 (en) Novel compounds
GB201803411D0 (en) Novel compounds